<DOC>
	<DOCNO>NCT00896662</DOCNO>
	<brief_summary>RATIONALE : Studying dendritic cell sample blood patient cancer receive aflibercept may help doctor learn effect aflibercept dendritic cell . PURPOSE : This laboratory study evaluate dendritic cell patient advance solid tumor non-Hodgkin lymphoma receive aflibercept clinical trial VGFT-ST-0202 .</brief_summary>
	<brief_title>Analysis Dendritic Phenotype Function Patients Receiving VEGF-Trap VGFT-ST-0202</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate effect vivo aflibercept presence different population dendritic cell ( DC ) immature cell ( ImC ) peripheral blood cancer patient characterize time course ( kinetics ) improvement antigen present cell ( APC ) phenotype ( decline DC/ImC ratio ) occur early late aflibercept administration . - Evaluate effect aflibercept administration DC function base ability stimulate antigen specific proliferative ( allogeneic tetanus toxoid ) cytolytic T cell response ( influenza ) characterizing time course ( kinetics ) improvement APC function occur early late aflibercept administration . - Explore relationship baseline aflibercept level host APC phenotype . OUTLINE : This multicenter study . Patients undergo phlebotomy blood collection baseline day 15 , 29 , 57 . Samples analyze dendritic cell phenotype , subpopulation , maturation status , function term ability activate autologous T cell .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<criteria>Diagnosis advance solid tumor nonHodgkin lymphoma enrol clinical trial VGFTST0202 Hemoglobin â‰¥ 10 g/dL Willing undergo phlebotomy none list PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult lymphoblastic lymphoma</keyword>
	<keyword>stage IV adult lymphoblastic lymphoma</keyword>
	<keyword>recurrent grade 1 follicular lymphoma</keyword>
	<keyword>recurrent grade 2 follicular lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>stage IV grade 1 follicular lymphoma</keyword>
	<keyword>stage IV grade 2 follicular lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
	<keyword>stage IV mantle cell lymphoma</keyword>
	<keyword>recurrent marginal zone lymphoma</keyword>
	<keyword>splenic marginal zone lymphoma</keyword>
	<keyword>stage IV marginal zone lymphoma</keyword>
	<keyword>nodal marginal zone B-cell lymphoma</keyword>
	<keyword>extranodal marginal zone B-cell lymphoma mucosa-associated lymphoid tissue</keyword>
	<keyword>recurrent small lymphocytic lymphoma</keyword>
	<keyword>stage IV small lymphocytic lymphoma</keyword>
</DOC>